Navigation Links
Healthcare Quality Catalyst Partners With Sequoia, Adds Three Healthcare Veterans
Date:11/16/2011

SALT LAKE CITY, Nov. 16, 2011 /PRNewswire/ -- Healthcare Quality Catalyst Corp. (www.hqcatalyst.com), the leader in healthcare data warehousing, today announced a series of important events since September 2011 to continue driving the company's substantial growth and industry leadership.

SEQUOIA CAPITAL INVESTMENT

On September 23, 2011, Healthcare Quality Catalyst (HQC) announced the selection of Sequoia Capital as its investment partner. The funds from Sequoia Capital's investment in HQC will be used to accelerate HQC's aggressive growth strategy by making its clinical data warehouse more widely available and developing additional software to expand care improvement for health systems. Michael Dixon, Partner at Sequoia Capital, will join HQC's Board of Directors.

"HQC's data warehousing solutions allow clinicians to harness the right data in order to simultaneously improve care and reduce cost," said Dixon. "We're excited to participate in this much-needed positive transformation in US healthcare."

DR. DAVID BURTON SELECTED AS CEO

On October 3, 2011, Dr. David Burton was selected as Chief Executive Officer of HQC.  Dr. Burton brings more than three decades of clinical and leadership experience to his position at the helm of HQC. Dr. Burton will focus on building out the management team and expanding the product line.

"It is an honor for me to lead HQC during this critical era for US health systems," declared Dr. Burton. "The addition to the team of key board members and senior leaders together with dramatic expansion of HQC's product offerings, positions us to help healthcare systems make fundamental
'/>"/>

SOURCE Healthcare Quality Catalyst
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. ViroPharma to Present at Three Upcoming Healthcare Conferences
4. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
5. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
6. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
7. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
11. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Minn. , June 30, 2015  EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering  of 40,229,886 units. Each ... of a Series A warrant to purchase one share ... warrant to purchase one share of common stock, at ...
(Date:6/30/2015)... June 30, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... 2015 Annual Meeting of StockholdersWhen:Tuesday, June 30 at 5:10 ... the Internet.  Simply log onto our website listed above. ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. ...
(Date:6/29/2015)... , June 29, 2015  Daktari Diagnostics was honored ... the Technology in the Service of Society Award. IEEE President ... Barry L. Shoop presented the award to Principal ... The ceremony was held Saturday, June 20, 2015, at the ... . "I have spent more than ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Daktari Honored with IEEE Spectrum Award 2
... leading provider of medical scrubs, is now accepting nominations through ... . The award provides the nation an opportunity to recognize ... duty to make a difference for their patients and the ... 9,000 healthcare professionals have been nominated for the award. To ...
... 2011 Wako Diagnostics, a division of Wako Chemicals ... and Drug Administration (FDA) to market the uTASWako i30 ... in vitro diagnostic (IVD) tests in the ... use by healthcare professionals as an aid in the ...
Cached Medicine Technology:Cherokee Inspired Comfort Award Calls for Healthcare Professional Nominations 2Cherokee Inspired Comfort Award Calls for Healthcare Professional Nominations 3Announcing 510(k) Clearance of a New Microfluidic-based IVD Test System, the uTASWako® i30 Immunoanalyzer, and AFP-L3 and DCP Assays for Liver Cancer Risk Assessment. 2
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... ... position as one of Medicare’s top-rated care centers in the country. To spread ... highlighting patient satisfaction and proving its facility is, indeed, worthy of five stars. ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... Good Neighbor Pharmacy’s premier event and tradeshow, taking place July 29 to August ... purchasing decision makers. , ThoughtSpot is a four-day event for independent ...
(Date:6/30/2015)... ... 2015 , ... ADVOCATE, the premier provider of radiology revenue ... billing agreements with Jackson Radiology Associates in Jackson, TN. , ADVOCATE ... billing process software functionality called Experience Based Technology (EBTTM). EBTTM improves radiology ...
(Date:6/30/2015)... ... June 30, 2015 , ... After many ... , finally its here, http://www.express-glasses.com is proud to announce its collaboration ... ask about shipping with DHL Express when calling or visiting the express glasses ...
(Date:6/30/2015)... ... ... Dr. Sammy Masri of Masri Sports Medicine &Wellness, NJ Top Doc, is ... treatment of non-surgical sports and other musculoskeletal injuries for both adults and children, for ... exercise to stay healthy and active. Dr. Masri seeks to provide his patients with ...
Breaking Medicine News(10 mins):Health News:Villa Health Care Center Announces Highest Care Rating in New Video 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 5
... ... a David versus Goliath struggle raging in the West, joins the stellar line-up ... York City and in Los Angeles (August 7 - 13). The film will ... the Reel Impact series on Planet Green, a network of Discovery Communications.,Split Estate ...
... , THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., ... Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ... Drug Administration (FDA) announcement regarding the results of a safety ... (infliximab), Enbrel(R) (etanercept), Humira(R) (adalimumab), Cimzia(R) (certolizumab pegol) and Simponi(R) ...
... delivery was vaginal or C-section doesn,t matter, study finds ... anesthesia during a Cesarean delivery doesn,t increase the risk ... , "We found that the incidence of learning disabilities ... those who were delivered via C-section but with general ...
... such as Enbrel, Remicade , TUESDAY, Aug. 4 (HealthDay ... Crohn,s disease and other inflammatory disorders must now carry ... and doctors that the medicines may boost cancer risk ... Administration announced Tuesday. , The drugs, called tumor ...
... of the genetic material of tumor cells are switched off ... labeling ranges among the epigenetic changes that do not change ... particularly often in genes which act as important inhibitors of ... why healthy cells and cancer cells differ in their methylation ...
... , , KING OF PRUSSIA, Pa., Aug. 4 ... health insurers in America, announced a 28 percent drop in profit ... Bertolini, Aetna,s president, attributed the loss to "higher claim intensity, such ... and procedures per visit, resulting in higher costs for emergency room, ...
Cached Medicine News:Health News:Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 2Health News:Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 3Health News:Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers 2Health News:Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers 3Health News:Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers 4Health News:Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers 5Health News:Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers 6Health News:Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers 7Health News:Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers 8Health News:Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers 9Health News:Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers 10Health News:Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers 11Health News:No Link Found Between Birth Anesthesia and Learning Issues 2Health News:Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk: FDA 2Health News:Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk: FDA 3Health News:Silenced genes as a warning sign of blood cancer 2Health News:Aetna 28 Percent Profit Drop Signals Storm Clouds for Healthcare 2
The URCA (Uric acid) method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of uric acid in serum, plasma and urine....
For the quantitative in vitro determination of apolipoprotein A-1 (apo A-1) in serum and plasma. For use as an aid if assessing the risk of coronary artery disease....
The GGT method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of g-glutamyl transferase activity in serum and plasma...
For the quantitative in vitro determination of Triglycerides in serum and plasma....
Medicine Products: